نتایج جستجو برای: gsk3β

تعداد نتایج: 1923  

Journal: :Neurobiology of disease 2015
Claudia Fuchs Roberto Rimondini Rocchina Viggiano Stefania Trazzi Marianna De Franceschi Renata Bartesaghi Elisabetta Ciani

Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5) gene have been identified in a rare neurodevelopmental disorder characterized by early-onset seizures, severe developmental delay, intellectual disability and Rett syndrome-like features. CDKL5 is highly expressed in the brain during early postnatal stages, suggesting its importance for brain maturation. Using a newly-generated Cd...

2013
Audrée De Montigny Ismaël Elhiri Julie Allyson Michel Cyr Guy Massicotte

The molecular mechanisms that regulate Tau phosphorylation are complex and currently incompletely understood. In the present study, pharmacological inhibitors were deployed to investigate potential processes by which the N-methyl-D-aspartate (NMDA) subtype of glutamate receptors modulates Tau phosphorylation in rat hippocampal slices. Our results demonstrated that Tau phosphorylation at Ser199-...

2014
Aishe A. Sarshad Martin Corcoran Bader Al-Muzzaini Laura Borgonovo-Brandter Anne Von Euler Douglas Lamont Neus Visa Piergiorgio Percipalle

Nuclear myosin 1c (NM1) mediates RNA polymerase I (pol I) transcription activation and cell cycle progression by facilitating PCAF-mediated H3K9 acetylation, but the molecular mechanism by which NM1 is regulated remains unclear. Here, we report that at early G1 the glycogen synthase kinase (GSK) 3β phosphorylates and stabilizes NM1, allowing for NM1 association with the chromatin. Genomic analy...

2016
Xuejuan Gao Junxia Feng Yujiao He Fengmei Xu Xiaoqin Fan Wensi Huang Haiting Xiong Qiuyu Liu Wanting Liu Xiaohui Liu Xuesong Sun Qing-Yu He Qihao Zhang Langxia Liu

c-FLIP (cellular FLICE-inhibitory protein) is the pivotal regulator of TRAIL resistance in cancer cells, It is a short-lived protein degraded through the ubiquitin/proteasome pathway. The discovery of factors and mechanisms regulating its protein stability is important for the comprehension of TRAIL resistance by tumor cells. In this study, we show that, when H1299 lung adenocarcinoma cells are...

2011
Katsuya Tanabe Yang Liu Syed D. Hasan Sara C. Martinez Corentin Cras-Méneur Cris M. Welling Ernesto Bernal-Mizrachi Yukio Tanizawa Christopher J. Rhodes Erik Zmuda Tsonwin Hai Nada A. Abumrad M. Alan Permutt

BACKGROUND The combination of elevated glucose and free-fatty acids (FFA), prevalent in diabetes, has been suggested to be a major contributor to pancreatic β-cell death. This study examines the synergistic effects of glucose and FFA on β-cell apoptosis and the molecular mechanisms involved. Mouse insulinoma cells and primary islets were treated with palmitate at increasing glucose and effects ...

2014
Julia Hernandez-Rapp Séverine Martin-Lannerée Théo Z. Hirsch Elodie Pradines Aurélie Alleaume-Butaux Benoît Schneider Anne Baudry Jean-Marie Launay Sophie Mouillet-Richard

The cellular prion protein, PrP(C), is a glycosylphosphatidylinositol-anchored protein, abundant in lipid rafts and highly expressed in the brain. While PrP(C) is much studied for its involvement under its abnormal PrP(Sc) isoform in Transmissible Spongiform Encephalopathies, its physiological role remains unclear. Here, we report that GSK3β, a multifunctional kinase whose inhibition is neuropr...

Journal: :Oncology reports 2015
Yan Ye Xiao-Juan Chao Jin-Feng Wu Brian Chi-Yan Cheng Tao Su Xiu-Qiong Fu Ting Li Hui Guo Anfernee Kai-Wing Tse Hiu-Yee Kwan Juan Du Gui-Xin Chou Zhi-Ling Yu

Novel agents need to be developed to overcome the limitations of the current melanoma therapeutics. Atractylenolide I (AT-I) is a sesquiterpene compound isolated from atractylodis macrocephalae rhizoma. Previous findings demonstrated that AT-I exhibited cytotoxic action in melanoma cells. However, the molecular mechanisms of AT‑1's anti-melanoma properties remain to be elucidated. In the presen...

Journal: :Cancer prevention research 2014
Zhiqiang Zhao Jun-qiang Yin Man-si Wu Guohui Song Xian-biao Xie Changye Zou Qinglian Tang Yuanzhong Wu Jinchang Lu Yongqian Wang Jin Wang Tiebang Kang Qiang Jia Jingnan Shen

Numerous patients with osteosarcoma either are not sensitive to chemotherapy or develop drug resistance to current chemotherapy regimens. Therefore, it is necessary to develop several potentially useful therapeutic agents. Dihydromyricetin is the major flavonoid component derived from Ampelopsis grossedentata, which has a long history of use in food and medicine. The present study examined the ...

2015
Bo Pan Jiezhong Chen Jiamei Lian Xu-Feng Huang Chao Deng Consuelo Walss-Bass

Aripiprazole is a wide-used antipsychotic drug with therapeutic effects on both positive and negative symptoms of schizophrenia, and reduced side-effects. Although aripiprazole was developed as a dopamine D2 receptor (D2R) partial agonist, all other D2R partial agonists that aimed to mimic aripiprazole failed to exert therapeutic effects in clinic. The present in vivo study aimed to investigate...

Journal: :Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2016
Chi Zhang Songlin Liu Xianrui Yuan Zhongliang Hu Haoyu Li Ming Wu Jian Yuan Zijin Zhao Jun Su Xiangyu Wang Yiwei Liao Qing Liu

BACKGROUND Valproic acid (VPA), an established antiepileptic drug, was assessed for antitumor activity, including its effects on glioblastoma, but its role has not been determined. METHODS In the present study, we investigated VPA-induced apoptosis effects on human U87 cells by cell viability, lactate dehydrogenase (LDH) release, TUNEL/Hoechst staining and flow cytometric in vitro, then we fu...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید